Scientific Updates for Improved Outcomes in Patients with Hepatocellular Carcinoma
Program Overview
This CME/CNE program will provide learners with an update regarding treatment and management of patients with hepatocellular carcinoma (HCC) through an interactive panel format. The expert faculty will first set the stage for modern day HCC care, reviewing the science, prevalence and current treatment guidelines. Recent clinical trial data of first line, second line and combination therapies will ...View Course
Best Practices for the Management of Non-Small Cell Lung Cancer
Program Overview
This CME/CNE activity will review recent advances in patients with non-small cell lung cancer (NSCLC) incorporating data presented at the European Society For Medical Oncology (ESMO) 2018 Conference in Munich, Germany. The three expert faculty will analyze clinical trial data on the current science and emerging best practices for the treatment of NSCLC. The faculty will also discuss how ...View Course
Scientific Updates for the Advanced Management of Idiopathic Pulmonary Fibrosis
Program Overview
This CME/CNE program will outline recent advances in the treatment and management of idiopathic pulmonary fibrosis (IPF), incorporating data presented at the 2018 American College of Chest Physicians (CHEST) Annual Meeting in San Antonio, Texas. Three expert faculty, led by Dr. Fernando Martinez, will review and compare recent guidelines/criteria as it relates to therapeutic decision making in the ...View Course
Scientific Updates to Improve Outcomes in Patients with Pulmonary Arterial Hypertension
Program Overview
This CME activity will discuss recent advances in the treatment and management of patients with pulmonary arterial hypertension (PAH). The expert faculty will provide learners with a scientific update regarding current evidence-based guidelines and appropriate diagnostic strategies. Recent clinical trial data of new and emerging therapeutic options for the treatment of PAH will be reviewed. The faculty will ...View Course
The Advances in Monoclonal Antibody Therapeutics to Improve Outcomes in Patients With Psoriatic Arthritis and Ankylosing Spondylitis
Program Overview
This CME/CNE activity is derived from content presented at the International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) Annual Meeting in Dallas, Texas. The expert faculty, Dr. Alvin F. Wells, will review the characteristics of both psoriatic arthritis (PsA) and ankylosing spondylitis (AS) to ensure accurate detection and early diagnosis. Recent guidelines for the treatment and management of ...View Course
Novel Treatment Strategies for Multiple Sclerosis: S1P-Based Therapeutics and the Role of Combination Therapy
Program Overview
This continuing education activity will focus on treatment strategies for patients with multiple sclerosis, utilizing S1P-based therapeutics and combination therapy. Four expert faculty will review new and emerging clinical trial data of S1P-based therapeutics. The faculty will also discuss the data and rationale for utilizing combination therapeutics in managing patients with multiple sclerosis. A review of how to ...View Course
Scientific Update on Pulmonary Arterial Hypertension
Program Overview
In this module of a Four-Part Expert Interview Series, Inderjit Singh, MBChB, BMedSci, MRCP, along with Aaron B. Waxman, MD, PhD, course chair, will provide a scientific update of pulmonary arterial hypertension (PAH), including the evolution of therapeutic options. The clinical relevance of various precision PAH therapeutics will be debated, among other topics. The role of exercise hemodynamics ...View Course
Applying Evidence-based Strategies to Patient-Centered Care in PAH
Program Overview
In this module of a Four-Part Expert Interview Series, Jeffrey Voner, MSHS, MPH, PA-C, DFAAPA, along with Aaron B. Waxman, MD, PhD, course chair, will outline recent treatment data for pulmonary arterial hypertension (PAH) as it relates to interprofessional patient care. Best practices for managing heart failure will be reviewed along with potential treatment directions after a confirmed ...View Course
Understanding Treatment Options for PAH
Program Overview
In this module of a Four-Part Expert Interview Series, R. James White, MD, along with Aaron B. Waxman, MD, PhD, course chair, will review advancements in the treatment and management of pulmonary arterial hypertension (PAH). The pipeline of available therapies will be relayed, along with strategies for selecting optimal single/combination therapies for PAH patients. The clinical relevance of ...View Course
Achieving an Earlier Diagnosis in Pulmonary Arterial Hypertension
Program Overview
In this module of a Four-Part Expert Interview Series, Evelyn Horn, MD, along with Aaron B. Waxman, MD, PhD, course chair, will discuss best practices for achieving an earlier diagnosis in pulmonary arterial hypertension (PAH). Data supporting early intervention will be analyzed along with risk factors for PAH and screening recommendations derived from current guidelines. The faculty will ...
View Course
